The Market Access for Precision Medicine Summit 2017 (formerly World CDx: Regulation & Reimbursement Summit) will bring together pharma, biotech, CDx developers, FDA and payers to provide much needed clarity on key regulatory, reimbursement and commercialization challenges facing precision medicine and diagnostic products.
MA4PM 2017 is curated for drug developers, hence it will provide insight on harnessing the likes of health economics, companion diagnostics, RWE and clinical labs to help you achieve your market access goals. Due to the increasing demand for clinical utility and the emphasis on delivering value for all stakeholders, this summit will foster much needed discussion and collaborate to ensure drug and diagnostic products reach the right patient, at the right time and the right cost.
"I thought it was a great meeting that allowed good interactions and time and space to process the information. It is always great to have representatives of the FDA join the meeting. Their perspective is so important."
"A very informative meeting. As a regulator, it was very helpful to learn about the reimbursement challenges faced by industry. "